Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet Godt Smil Aalborg ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 1.5% 0.5%   Bankruptcy risk   16.7% 5.0% 5.1% 1.1% 1.2% 1.3% 8.8% 7.4%   Credit score (0-100)   11 45 43 83 83 79 28 33   Credit rating   BB BBB BBB A A A BB BB   Credit limit (kDKK)   -0.0 0.0 0.0 311.6 282.0 147.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   6,476 11,604 14,013 18,108 21,707 23,369 0.0 0.0   EBITDA   -895 1,217 2,468 4,301 4,566 3,911 0.0 0.0   EBIT   -1,582 547 1,847 3,656 3,808 3,116 0.0 0.0   Pre-tax profit (PTP)   -1,793.3 341.8 1,697.0 3,599.7 3,766.2 3,061.1 0.0 0.0   Net earnings   -1,393.5 272.0 1,328.6 2,806.9 2,937.4 2,383.8 0.0 0.0   Pre-tax profit without non-rec. items   -1,793 342 1,697 3,600 3,766 3,061 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   3,215 3,070 2,631 2,924 2,882 7,691 0.0 0.0   Shareholders equity total   -2,156 -1,884 -556 2,251 2,688 2,072 1,697 1,697   Interest-bearing liabilities   287 256 270 867 551 3,156 0.0 0.0   Balance sheet total (assets)   6,983 7,224 7,057 7,246 6,594 11,364 1,697 1,697   Net Debt   281 120 -99.5 -849 -565 2,631 -1,356 -1,356     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   6,476 11,604 14,013 18,108 21,707 23,369 0.0 0.0   Gross profit growth   12.2% 79.2% 20.8% 29.2% 19.9% 7.7% -100.0% 0.0%   Employees   14 15 17 19 21 22 0 0   Employee growth %   16.7% 7.1% 13.3% 11.8% 10.5% 4.8% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   6,983 7,224 7,057 7,246 6,594 11,364 1,697 1,697   Balance sheet change%   -4.1% 3.5% -2.3% 2.7% -9.0% 72.3% -85.1% 0.0%   Added value   -895.4 1,217.0 2,467.8 4,301.3 4,452.7 3,911.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,332 -947 -1,191 -484 -932 3,882 -7,691 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -24.4% 4.7% 13.2% 20.2% 17.5% 13.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -17.9% 6.5% 22.7% 49.4% 55.3% 35.0% 0.0% 0.0%   ROI %   -58.4% 23.7% 77.5% 117.4% 101.5% 65.4% 0.0% 0.0%   ROE %   -19.5% 3.8% 18.6% 60.3% 118.9% 100.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -23.9% -21.4% -7.7% 32.5% 42.9% 19.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -31.4% 9.9% -4.0% -19.7% -12.4% 67.3% 0.0% 0.0%   Gearing %   -13.3% -13.6% -48.5% 38.5% 20.5% 152.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   98.4% 91.7% 75.4% 12.1% 8.8% 4.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.3 0.3 0.5 0.9 1.1 0.3 0.0 0.0   Current Ratio   0.3 0.4 0.6 1.0 1.1 0.4 0.0 0.0   Cash and cash equivalent   6.1 136.1 369.2 1,715.4 1,116.5 524.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -4,654.8 -4,194.6 -2,339.8 -180.2 380.6 -5,060.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -64 81 145 226 212 178 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -64 81 145 226 217 178 0 0   EBIT / employee   -113 36 109 192 181 142 0 0   Net earnings / employee   -100 18 78 148 140 108 0 0